****** is one of the most devastating diseases mankind has every faced. Even after years of research, scientists still haven’t found one definitive cure to eradicate ****** for good! While methods like chemotherapy, radiation therapy, and use of various ***** have been successful to some degree, they don’t always work for everyone and a lot of patients still die each day due to ******.
But a study made by Dutch scientists could be the answer to the long sought-after solution for the ****** problem.
Presented at the European Breast ****** Conference in Amsterdam, the research led by Professor Nigel Bundred shows promising results, with ****** cells completely destroyed in a statistically significant number of study subjects within just 11 days!
The study uses a combination of ****** ***** Herceptin (trastuzumab) and Lapatinib. Today, Herceptin is only licensed to be used along with chemotherapy but the positive results of the Dutch study could soon change this.
In the study, 257 women with HER2 positive breast ****** were divided into two groups. The women in the control group were only given Herceptin while the drug group received a combination of Herceptin and Lapatinib.
After just 11 days, 17% of the group given the drug combination showed dramatically shrunken tumors and an amazing 11% showed no ****** cells at all! Whereas the control group had no one or 0% with no ****** cells remaining, and only 3% showed a reduction in tumor size.
It was clear that the drug combination had a very good effect to those who received it; although more studies need to be done as not everyone was able to achieve excellent results with the treatment.
A lot of work still needs to be done to further study the drug combination and eventually get it licensed to be used together but this is already a major step! No wonder the scientific community is so excited over this news! Isn’t this awesome?